Life Science Association of Manitoba Newsletter: June 6, 2011

Jun 6, 2011 | Corporate Member News

In this issue:

Member & Local News

  • Small Tech Firms get Funding Boost 
  • Kane Biotech Awarded Contract by the United States Army to Develop Antibiofilm-Antimicrobial Wound Gel   
  • Miraculins to Receive $100,000 Grant for PreVu Non-Invasive Cholesterol Test Through the Technology Commercialization Program 
  • High-tech IMRIS Banks on the Future 

Life Science in the News  

  • Canadian Vaccine Offers Hope for Global Scourge of E. coli   
  • Increasing Global Food Security Through Technology 
  • Taking a Long View: New Agricultural Biotechnology Research  
  • Histogenics Raises $34 Million After ProChon Biotech Merger 
  • Cell-Phone Use Possibly Cancer-Causing, WHO Group Says 

Access the newsletter here

About the Life Science Association of Manitoba (LSAM): 

LSAM represents all those involved in the Life Science Sector in Manitoba. The Life Science Sector focuses on the use of innovative biological tools and products, the creation of wealth and sustainability in the production of medical treatments, diagnostics, more-nutritional foods, energy, chemicals, and materials, while improving the quality of the environment.

The Life Science sector is a key to economic growth within the Province of Manitoba and is currently estimated to contribute more than 7% of the province’s GDP. In addition to generating value on its own, the Life Science sector is helping to grow and sustain competitiveness in ailing and traditional sectors of the economy, through the application of new and innovative products and processes. 

To find out more about LSAM visit its website here

Similar Posts